666

TRANSCENTA HOLDING LTD

No trades
See on Supercharts

6628 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Transcenta Holding Ltd. is a clinical stage global biopharmaceutical company, which engages in discovery, research, development, and manufacturing of differentiated antibody therapies in therapeutic areas with high unmet medical needs. It focuses on oncology, nephrology, and bone diseases. The firm also develops Immune Tolerance Breaking technology platform to build a diversified and risk-balanced pipeline of antibodies. The company was founded on August 20, 2010 and is headquartered in Suzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

6628 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company